Symbiotic-Lung-01: a phase 3 trial of a PD-1/VEGF bispecific antibody, tivunatamig (PF-08634404,) vs pembrolizumab in combination with platinum-based chemotherapy in first-line for locally advanced or metastatic non-small cell lung cancer
Web preview is not available
Try directly downloading the file.